FreeCME

Molecular Profiling and Targeted Therapies Shifting the Paradigm for Cholangiocarcinoma (Bile Duct Cancer)

CME: 0.5

November 12, 2020
KEYWORDS Primary Care
/ Print / Reprints /
| Share More
/ Text Size+

Post a comment to this article